Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce

benzinga.com/news/health-care/25/11/48811177/metagenomi-prioritizes-hemophilia-a-program-lays-off-25-workforce

Metagenomi, Inc. (NASDAQ:MGX) on Tuesday shared new dose range finding data from its MGX-001 hemophilia A program.
MGX stock is struggling to find support. Check out the latest moves here
The data demonstrated curative factor VIII (FVIII) activity in non-human primates (NHPs) and informs…

This story appeared on benzinga.com, 2025-11-12 17:09:41.
The Entire Business World on a Single Page. Free to Use →